Clinical Trial Update: Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating temozolomide in combination with bevacizumab for metastatic intraocular melanoma (eye melanoma). The current status is UNKNO…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraocular Melanoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Institut Curie | Conditions: Intraocular Melanoma | Phase 2 | Status: UNKNOWN